Login / Signup

The Phase 3 INVIGORATE Trial of Reproxalap in Patients with Seasonal Allergic Conjunctivitis.

Christopher E StarrKelly K NicholsJacob R LangTodd C Brady
Published in: Clinical ophthalmology (Auckland, N.Z.) (2023)
NCT04207736.
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • allergic rhinitis
  • randomized controlled trial
  • open label